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Summary: Erythrocyte membrane fluidity is related to their
rheologic behavior, the dynamic quality of erythrocytes,
which is tempted in hypertension and atherosclerosis. An
increased risk of these and other cardiovascular diseases
occurs in ageing women. Menopause-related conditions are
often treated with hormone replacement therapy that may
increase the risk of malignancies. Vitex agnus-castus L.
essential oil contains various organic compounds (monoter-
penes, sesquiterpenes and terpenoids), and is increasingly
used as an alternative therapy for menopausal symptoms.
These components of the oil may be incorporated into cell
membranes, thereby changing the membrane fluidity. The
aim of this study was to determine the effects of Vitex agnus-
castus essential oil on human erythrocyte membrane fluidity
at graded depths. We used Electron Paramagnetic Reso -
 nan ce spectroscopy and fatty acid spin probes (5-doxyl
stearic acid and 12-doxyl stearic acid), whose spectra
depend on membrane fluidity. After treatment with Vitex
agnus-castus essential oil the erythrocytes had a significant
(p=0.029) and reversible increase in membrane fluidity in
the deeper hydrophobic membrane regions, with no change
(p>0.05) in fluidity near the membrane’s hydrophilic sur-
face. These results document increased fluidity of the human
erythrocyte membrane by Vitex agnus-castus essential oil,
and this action may be useful in patients with menopause- 
-related hypertension and other cardiovascular conditions. 
Keywords: erythrocytes, membrane fluidity, Vac essential
oil, EPR
Kratak sadr`aj: Fluidnost membrane eritrocita uslovljava
njihove reolo{ke karakteristike, svojevrsne dinami~ke kva li -
tete, izmenjene u hipertenziji i aterosklerozi. Rizik od na -
vedenih i drugih kardiovaskularnih oboljenja se kod `ena
po ve}ava sa sta renjem. Tegobe koje prate menopauzu se
obi~no ubla`avaju supstitucionom hormonskom terapijom,
koja mo`e pove}ati rizik od pojave malignih oboljenja. Esen -
cijalno ulje biljke Vitex agnus-castus L. sadr`i razli~ita organ-
ska jedinjenja (monoterpene, seskviterpene i terpenoide) i sve
~e{}e se koristi kao alternativno terapijsko sredstvo za simp-
tome me no pauze. Navedene komponente esencijalnog ulja
mogu se ugraditi u }elijske membrane i menjati njihovu flu-
idnost. Cilj studije bio je da se utvrde efekti esencijalnog ulja
biljke Vitex agnus-castus na fluidnost membrane eritrocita po
njenoj du bini. Kori{}ena je spektroskopija elektronske para-
magnetne rezonance i masnokiselinske spinske probe (5-
dok sil stea rinska i 12-doksil stearinska kiselina), ~iji spektri
za vise od fluidnosti membrane. Nakon tretmana eritrocita
esencijal nim uljem biljke Vitex agnus-castus utvr|eno je
zna~ajno (p=0,029) i reverzibilno pove}anje fluidnosti nji-
hove membrane u dubljim, hidrofobnim regionima, dok u
povr{inskim, hidrofilnim regionima eritrocitne membrane
nisu utvr|ene zna~ajne promene (p>0,05). Ovi rezultati
uka zuju na po ve}anje fluidnosti eritrocitne membrane
nakon tretmana esencijalnim uljem biljke Vitex agnus-cas-
tus, {to mo`e biti ko ristan efekat pri tretmanu pacijentkinja sa
hipertenzijom i drugim kardiovaskularnim oboljenjima u
menopauzi.
Klju~ne re~i: eritrociti, fluidnost membrane, Vac esenci -
jalno ulje, EPR
List of Abbreviations: Vac, Vitex agnus-castus; EPR, Electron
Paramagnetic Resonance; GC, gas chromatography; GC/MS,
gas chromatography-mass spectrometry; FID, flame ioniza-
tion detector; EI, electron impact; DS, doxyl stearic acid; S,
order parameter.
J Med Biochem 2012; 31 (3) 223
Introduction
Hormone replacement therapy is a common
therapeutic approach to treat symptoms in ageing
women. Estrogens have reduced the morbidity relat-
ed to coronary heart diseases in postmenopausal
women (1) but estrogen replacement therapy has
also increased the risk of breast cancer (2) and the
frequency of thromboembolic events (3). Considering
the potential risks of estrogen replacement in meno -
pausal women, increasing attention is being focused
on alternative, plant-based therapy for menopausal
symptoms, including those related to the cardiovascu-
lar system. Soybean isoflavones (isolated or as a part
of complex formulas) are often exploited for this pur-
pose (4) although they may have disruptive effects on
the endocrine system, potentially resulting in cell trans -
formation and cancer (5). Also, essential oils from
aromatic plants, which may have useful therapeutic
potential, are increasingly used to treat a wide spec-
trum of age-dependent diseases (6). Germane to this,
essential oil from both the berry and the leaf of the
chaste tree (Vitex agnus-castus L., Verbenaceae; Vac),
native to the Medi ter ranean and Central Asia, has
been found to be effective in the treatment of ageing
symptoms in women (7). 
Serious cardiovascular risks related to meno -
pause are mainly due to estrogen deficiency, and
include, inter alia, changes in lipid profiles, obesity,
hypertension and atherosclerosis (8, 9). It has been
suggested that cell membrane alterations are respon-
sible for certain blood pressure disorders (10). The
fluidity of the erythrocyte membrane is an important
determinant that modulates their rheologic behavior
and is a main feature defining blood viscosity (11);
this property is related to hypertensive and atheroscle-
rotic disease. For example, the membrane fluidity of
erythrocytes is reduced in both spontaneously hyper-
tensive rats and patients with essential hypertension,
when compared to normotensive controls (12, 13).
Also, the fatty acid profile of the erythrocyte mem-
brane defines its physicochemical properties, i.e., flu-
idity/viscosity (14, 15). Because lipid profiles are al -
te red in menopause, the possibility arises for chan ges
in the erythrocyte membrane properties to occur
that may be at least partially responsible for increased
cardiovascular risks. Therefore, therapeutic agents ca -
 pa ble of increasing the fluidity of the erythrocyte mem -
brane could be beneficial for treating hypertension
and other cardiovascular complications associated
with menopause.
The aim of this study was to determine if Vac
essential oil (a mixture of various monoterpenes,
sesquiterpenes and terpenoids (Figure 1)), modulates
erythrocyte membrane fluidity in a manner that would
be favorable for use in the treatment of menopausal
symptoms. Namely, such information could be impor-
tant to determine the utility of Vac essential oil in
hypertension and atherosclerosis, that frequently
occur in elderly women.
In order to evaluate the essential oil effects, we
used Electron Paramagnetic Resonance (EPR) spec-
troscopy and lipophilic spin-probes which intercalate
the membrane and whose EPR spectra are affected
by membrane fluidity. Namely, EPR measurements
provide the calculation of the order parameter (S)
which is reciprocally proportional to the membrane
fluidity. This method revealed a specific and signifi-
cant effect of the essential oil on the human erythro-
cyte membrane that is compatible with potentially
beneficial effects for menopausal women.
Materials and Methods 
Plant material and essential oil preparation
Ripe Vac berries were identified and collected
from June through October 2007 by Prof. Dr. Dragan
Grubi{i}† (Department of Plant Physiology, Institute
for Biological Research »Sini{a Stankovi}«, Belgrade,
Serbia) in Igalo, Montenegro. A voucher specimen
(No VAC23987) has been deposited at the Institute
for Biological Research »Sini{a Stankovi}«. Material
was dried at room temperature. Vac essential oil was
prepared by hydrodistillation in a Clevenger type
Figure 1 The chemical structures of organic compounds
prevalent in the Vac essential oil. The proportions of major
components are shown as percentages.
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apparatus for 3 h. The yield of the oil was 0.72%. The
obtained essential oil was stored at +4 °C until test-
ing. 
Gas chromatography (GC) and gas chromatog-
raphy-mass spectrometry (GC/MS)
Qualitative and quantitative analyses of the oil
were performed using GC and GC/MS. The GC
analysis of the oil was carried out on a GC HP-5890
II apparatus, equipped with a split-splitless injector,
attached to an HP-5 column (25 m × 0.32 mm, 0.52
mm film thickness) and fitted to a flame ionization de -
tector (FID). Carrier gas flow rate (H2) was 1 mL/min,
split ratio 1:30, injector temperature was 250 °C,
detector temperature 300 °C, while column tempera-
ture was linearly programmed from 40 to 240 °C (at
a rate of 4°/min). The same analytical conditions
were employed for the GC/MS analysis, where the HP
G 1800C Series II GCD system equipped with an
HP-5MS column (30 m × 0.25 mm, 0.25 mm film
thickness) was used. The transfer line was heated at
260 °C. Mass spectra were acquired in electron im -
pact (EI) mode (70 eV), in m/z range 40–400. Elec -
tron impact identification of individual constituents
was made by comparison of their retention times with
those of ana lytical standards of the available terpe -
noids, and by com puter searching, matching mass
spectra with those filed in the Wiley 275 library of
mass spectra. Confirmation was obtained using the
calibrated AMDIS program for the determination of
experimental values for retention indices of the recor -
ded constituents and by comparing them with values
from the literature (16). For quantification purposes,
area percent data obtained by FID were used. The
content of particular compounds was calculated from
the GC peak areas, using the normalization method.
According to the analyses, the following compounds
were prevalent in the Vac essential oil: 1,8-cineole
(16.3%), sabinene (13.4%), a-pinene (9.4%), trans-
b-far nesene (9.3%), limonene (6.8%), a-terpinyl
acetate (4.6%), caryop hyllene oxide (4.6%) and trans-
b-caryophyllene (4.1%) (Figure 1) (17). 
Erythrocyte sample preparation 
Fresh blood was obtained from four healthy vol-
unteers between the ages of 30 and 35 years, using
tubes containing 0.072 mL of 7.5% K3EDTA as the
anticoagulant per 3 mL of blood (Vacuette EDTA;
Greiner Bio-One, Kremsmünster, Austria). The ery-
throcytes (erythrocyte membranes) were spin-labeled
as described previously (18). Fresh blood erythrocytes
were washed three times with isotonic phosphate-
buffered saline (PBS; NaCl 8.8 g/L, Na2HPO4 1.2
g/L, NaH2PO4 0.43 g/L, pH 7.4) by centrifugation at
2500 g for 10 min at 4 °C. The hematocrit for fresh
blood was ∼ 40%, and all samples were adjusted to
the same hematocrit before incubation. Aliquots of
Vac essential oil were added to the washed erythro-
cytes to obtain the final ratio of 0.7 mL/mL. This con-
centration was selected in order to mimic in vivo le vels
in the blood of menopausal women exposed to der-
mal application of Vac essential oil (19). The control
samples contained erythrocytes untreated with the
oil. All samples were gently shaken at 37 °C for 20
minutes, and coagulation was absent during the pro-
cedure. To determine the reversibility of potential
chan ges in the fluidity of the erythrocyte membrane,
a part of each sample was taken and gently washed
three times with PBS. 
EPR measurements
Ethanol solutions of the fatty acid spin-probes 5-
doxyl stearic acid (5-DS) and 12-doxyl stearic acid
(12-DS) (2-(3-carboxypentyl)-2-tridecyl-4,4-dimethy-
loxazolidine-3-oxyl and 2-(10-carboxydecyl)-2-hexyl-
4,4-dimethyloxazolidine-3-oxyl; (Molecular Probes,
Junction City, OR, USA)) were applied to the walls of
tubes. EPR with 5-DS provides information about the
fluidity near the hydrophilic membrane surface, while
12-DS has a nitroxide (EPR active) structure farther
down the lipid acid chain (at carbon 12 from the car-
boxyl group), thus providing information on the fluid-
ity of deeper membrane regions (20). The amount of
DS to be used was calculated to obtain the optimal
spin-label/membrane-lipid ratio of approximately
1:100 (21). After the ethanol was completely evapo-
rated, the sample was added and gently mixed.
Evaporation of ethanol was necessary to prevent its
potential effect on erythrocyte membrane fluidity.
Samples were placed in Teflon tubes with a wall thick-
ness of 0.025 mm and an internal diameter of 0.6
mm (Zeus Industries, Raritan, NJ) and inserted into
quartz capillaries. The incubation and EPR measure-
ments were performed in air. EPR spectra were
recorded using a Varian E104-A EPR spectrometer
(Palo Alto, CA, USA) operating at X-band (9.1 GHz)
and adjusted to the following settings: modulation
amplitude, 2 G; modulation frequency, 100 kHz; mi -
cro wave power, 10 mW; scan range, 100 G; scan ti me,
4 min; time constant, 0.25 s. The temperature was
controlled at 20 °C during the measurements. Spec -
tra were recorded and analyzed using EW software
(Scientific Software Inc., Bloomington, IL). The order
parameter (S), which is reciprocally proportional to
fluidity, was calculated as described previously (22).
All procedures related to the use of human blood in
this study conformed to the recommendation provid-
ed in the Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments
involving humans. 
Statistical analysis
The data are presented as means ± standard
deviation (SD) for at least five separate experiments.
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Significance differences were calculated by the non-
parametric two-tailed Mann-Whitney test. Means
were considered significantly different at p<0.05.
Results
We used two spin-probes, 5-DS and 12-DS, for
this study in order to explore the effects of Vac essen-
tial oil on the erythrocyte membrane at graded depths.
Figure 2 shows the characteristic EPR spectra of un -
treated erythrocytes or erythrocytes treated with Vac
essential oil, labeled with 5-DS (near the hydrophilic
membrane surface, Figure 2A) or 12-DS (in the deep-
er membrane regions, Figure 2B). The calculated
order parameters (S) of the erythrocyte membrane
labeled with 5-DS and 12-DS are summarized in
Table I. Con si dering that the order parameter is re ci -
procally proportional to the membrane fluidity, it was
determined that Vac essential oil significantly
(p=0.029) incre ased membrane fluidity in the deep-
er, hydrophobic membrane regions, without affecting
(p>0.05) fluidity near the membrane hydrophilic sur-
face. The obser ved changes of fluidity in the deeper
membrane regions were reversible, as the order para -
meter of the membranes of erythrocytes that were
treated with Vac essential oil and then washed had
a value similar (p>0.05) to the order parameter ob -
tai ned in washed controls. Although not part of our
study design, we noted that even gentle washing de -
creased erythrocyte membrane fluidity when com-
pared to unwashed erythrocytes. This observation
should be considered in studies designed to evaluate
erythrocyte membrane properties.
Discussion
Advanced age in females implies an altered
physiologic status characterized by estrogen deficien-
cy that is accompanied by unfavorable changes in
lipid metabolism and increased cardiovascular mor-
bidity and mortality (9). Estrogen replacement thera-
py ameliorates post-menopausal symptoms, but seri-
ous side effects occur, including an increased risk of
breast cancer, especially when estrogens are com-
Figure 2 Characteristic EPR spectra of A) erythrocytes
labeled with 5-DS without (control; dark trace) or with Vac
essential oil (0.7 mL/mL; pale trace). B) Erythrocytes la be led
with 12-DS without (control; dark trace) or with Vac essen-
tial oil (0.7 mL/mL; pale trace); S, order parameter; 2TII,
outer hyperfine splitting; 2T subscript, inner hyperfine split-
ting; a, isotropic hyperfine coupling constant in crystal [a =
1/3(Txx + Tyy + Tzz)]; a’, isotropic hyperfine coupling con-
stant in membrane [a’ = 1/3(TII + 2T⊥)]; Txx, Tyy, Tzz,
hyperfine constants (for 5-DS they were taken to be Txx =
Tyy = 6.1 G, Tzz = 32.4 G; for 12-DS Txx = 6.26 G, Tyy =
5.81 G, Tzz = 33.46 G) (22). Dashed lines marking param-
eters in control spectra are shown in order to stress the dif-
ferences between controls and treated samples. Three nar-
row lines originate from the DSs in the solution (arrows)
(18, 22).
Table I Order parameters (S) obtained by using 5-DS and
12-DS in human erythrocytes exposed to the Vac essential
oil
Samples 5-DS (S) 
Statistical 
signifi-
cance 
12-DS (S) 
Statistical 
signifi-
cance  
Control 0.746 ± 0.004 – 0.609 ± 0.007 – 
Vac
essential 
oil 
0.736 ± 0.012 n.s. 0.585 ± 0.006 p = 0.029  
Control
+ wash 0.735 ± 0.009 – 0.631 ± 0.005** –
Vac
essential 
oil +
wash 
0.739 ± 0.006 n.s.* 0.626 ± 0.007** n.s.*  
* – Non-significant; 
** – The order parameter of washed erythrocytes (both con-
trol and pre-treated with Vac essential oil) determined using
12-DS was significantly (p<0.05) higher in comparison with
corresponding unwashed samples. Data are shown as
means ± S. D. 
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bined with progestational agents (2), an increased
rate of venous thromboembolic events (3) and signif-
icantly higher rates of cholecystitis (23). Such delete-
rious effects have limited the use of estrogen therapy.
As an alternative, soybean isoflavones have been
assessed as potential therapy for various cardiovascu-
lar issues and ageing symptoms. However, these also
have drawbacks (5, 24–26). Recently, emphasis has
been placed on therapeutically useful essential oils
from aromatic plants (6). One of these, Vac essential
oil, has shown promising effects in the treatment of
ageing symptoms in women (7). Cardiovascular con-
ditions related to female ageing include hypertension
and atherosclerosis, whose pathophysiology is linked
to changes in erythrocyte membrane fluidity (11) and
blood viscosity (27), while an increase of erythrocytes’
elastic deformability is the therapeutic imperative. 
In the present study, Vac essential oil had differ-
ing effects on erythrocyte membrane fluidity depend-
ing on depth. Namely, membrane fluidity was
increased (p=0.029) in the deeper, hydrophobic por-
tions of the membrane whereas it was unchanged
(p>0.05) near the hydrophilic surface of the erythro-
cyte. We exposed erythrocytes to low concentrations
of Vac essential oil in order to mimic in vivo levels
present in the blood of menopausal women exposed
to dermal application of the oil. Hence, these results
obtained in vitro are comparable to in vivo conditions,
and indicate that the application of Vac essential oil
may be expected to increase erythrocyte membrane
fluidity in the blood of treated subjects. Since the flu-
idity of the erythrocyte membrane strongly affects
their rheologic behavior/deformability which relate to
blood pressure (11–13), Vac essential oil could be
efficacious when hypertension and other cardiovascu-
lar problems related to menopause are present.
The main constituents of Vac essential oil are
various monoterpenes, sesquiterpenes and ter-
penoids. Most are small cyclic molecules without
polar groups (see Figure 1), and therefore hydropho-
bic. The current data imply that compounds in Vac
essential oil are preferentially positioned in the hydro -
phobic core of the membrane. Observed changes
after oil treatment were reversible, indicating that Vac
oil constituents affecting membrane fluidity are not
covalently bound to membrane lipids/proteins but,
rather, are intercalated into the membrane. Furher,
they dissociate from the membrane when they are
removed from the medium. This is in accordance with
previous results showing the accumulation of
monoterpenes in the cell membrane as well as rapid
release after re moving from the media (28). Anjos
and co-workers (29) have shown, using EPR with 5-
DS, that 1,8-cineole, a main constituent of Vac, mod-
ifies the properties of cell membranes by rupturing
the hydrogen-bonded network at the membrane–wa -
ter interface, but not by changing membrane fluidity
near the surface. Similar results were obtained for
limonene and other related compounds (30). The
ability to increase the susceptibility of the membrane
to the penetration of various compounds seems to be
a general characteristic of cyclic terpens (31). To date,
several constituents of Vac essen tial oil – 1,8-cineole,
a-pinene, limonene (31), have been used for increas-
ing percutaneous permeation and to facilitate the
passage of drugs through cellular membranes (32).
Judging from the present results, this property of
cyclic terpenes could be, in addition to the previously
proposed mechanism, explained by the decreased
level of order within the hydrophobic core of the
membrane. Germane to this idea, Vac essential oil
could represent a useful addition to facilitate percuta-
neous absorption of other agents. 
The presented results demonstrate a specific
and reversible increase of deep erythrocyte mem-
brane fluidity after Vac essential oil application, thus
raising the possibility of potential benefit in meno -
pausal women and the various cardiovascular condi-
tions common to this specific age. In addition, the
membrane effects of various organic compounds in
Vac essential oil that improve percutaneous absorp-
tion may be applicable to other areas of potential
therapeutic value. 
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